Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
Andrea Picchianti Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 384
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro Machado, Saskia Lawson‐Tovey, Anja Strangfeld, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 5, pp. 695-709
Open Access | Times Cited: 167
Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
Carla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
Neurology (2021) Vol. 98, Iss. 5
Open Access | Times Cited: 145
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
Féline P B Kroon, Aurélie Najm, Alessia Alunno, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 422-432
Open Access | Times Cited: 92
The role of IL-6 in coronavirus, especially in COVID-19
Xinyi Wang, Guozheng Tang, Yuchen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 57
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Yan Xie, Yang Liu, Yi Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 24-30
Open Access | Times Cited: 29
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study
Paolo Corradini, Chiara Agrati, Giovanni Apolone, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e426-e438
Open Access | Times Cited: 29
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
Alessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 841-849
Open Access | Times Cited: 29
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
David A. Jolliffe, Sian Faustini, Hayley Holt, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1601-1601
Open Access | Times Cited: 27
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Qiugang Zhu, Yan Xu, Ting Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
Kuo‐Tung Tang, Bo‐Chueh Hsu, Der‐Yuan Chen
Biomedicines (2022) Vol. 10, Iss. 4, pp. 834-834
Open Access | Times Cited: 26
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
Martina Fabris, G. De Marchi, Rossana Domenis, et al.
Journal of Autoimmunity (2022) Vol. 129, pp. 102827-102827
Open Access | Times Cited: 23
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
Germana Grassi, Stefania Notari, Simona Gili, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
Anwar I. Joudeh, Abdu Qaid Lutf, Salah Mahdi, et al.
Vaccine (2023) Vol. 41, Iss. 26, pp. 3801-3812
Open Access | Times Cited: 12
Novel insights into the management of rheumatoid arthritis: one year in review 2022
Carlo Garaffoni, Antonella Adinolfi, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology (2022)
Open Access | Times Cited: 21
Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases
Özlem Akgün, Figen Çakmak, Vafa Guliyeva, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 11, pp. 4482-4490
Open Access | Times Cited: 20
Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis
Jeffrey T. Guptill, John W. Sleasman, Sophie Steeland, et al.
Autoimmunity (2022) Vol. 55, Iss. 8, pp. 620-631
Open Access | Times Cited: 18
Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Constantin Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11149-11149
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top